(Q48751421)

English

Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men.

scientific article published in March 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

Cremer P

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

Nagel D

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

Mann H

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

Labrot B

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

Müller-Berninger R

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

Elster H

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

Seidel D

7

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

publication date

1 March 1997

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

129

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

221-230

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

Risk factor analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Cholesterol and coronary heart disease. Future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Are apolipoproteins better discriminators than lipids for atherosclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Lipoprotein (a). Heterogeneity and biological relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Atherosclerosis and the coagulation system

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

A prospective study of lipoprotein(a) and the risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

The electrocardiogram in population studies. A classification system

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

The response-to-retention hypothesis of early atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Summary estimates of cholesterol used to predict coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Plasma triglyceride level and mortality from coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Adsorption and coagulability of fibrinogen on atheromatous lipid surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Lipoproteins and atherogenesis. Current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2906030-3

7 January 2021

Identifiers

10.1016/S0021-9150(96)06030-3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9105565

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48751421&oldid=1373623405"